Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
June 26, 2012
[Genetic background of acute coronary syndrome]
Eiji Yahiro, Keijiro Saku
Current Pharmaceutical Design
|
November 27, 2012
Non-ACE pathway-induced angiotensin II production
Yoshinari Uehara, Shin-ichiro Miura, Eiji Yahiro, et al.
Pediatric Cardiology
|
January 24, 2009
Insights into the characteristics of mammalian cardiomyocyte terminal differentiation shown through the study of mice with a dysfunctional c-kit
Nawazish Naqvi, Ming Li, Eiji Yahiro, et al.
Current Pharmaceutical Design
|
November 27, 2012
Chymase inhibitors
Eiji Yahiro, Shin-ichiro Miura, Satoshi Imaizumi, et al.
Current Pharmaceutical Design
|
November 27, 2012
Class- and molecule-specific differential effects of angiotensin II type 1 receptor blockers
Satoshi Imaizumi, Shin-ichiro Miura, Eiji Yahiro, et al.
International Journal of Cardiology. Heart & Vessels
|
February 17, 2018
Improved survival rate after myocardial infarction using an inducible cholesterol efflux (iCE) peptide: FAMP
Eiji Yahiro, Yoshinari Uehara, Emi Kawachi, et al.
Experimental and Clinical Cardiology
|
July 25, 2008
Orally administered levofloxacin as prophylaxis against pacemaker infection
Natsumi Morito, Yoshio Yamanouchi, Sunao Kodama, et al.
Cardiology
|
April 25, 2003
Reperfusion-induced arrhythmias are suppressed by inhibition of the angiotensin II type 1 receptor
Eiji Yahiro, Munehito Ideishi, Li Xing Wang, et al.
Journal of Cardiovascular Pharmacology
|
April 12, 2003
Chymase inhibitor improves survival in hamsters with myocardial infarction
Fumihiro Hoshino, Hidenori Urata, Yukiko Inoue, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 4, 2015
Depressor effect of chymase inhibitor in mice with high salt-induced moderate hypertension
Sankar Devarajan, Eiji Yahiro, Yoshinari Uehara, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
June 26, 2012
[Genetic background of acute coronary syndrome]
Eiji Yahiro, Keijiro Saku
Current Pharmaceutical Design
|
November 27, 2012
Non-ACE pathway-induced angiotensin II production
Yoshinari Uehara, Shin-ichiro Miura, Eiji Yahiro, et al.
Pediatric Cardiology
|
January 24, 2009
Insights into the characteristics of mammalian cardiomyocyte terminal differentiation shown through the study of mice with a dysfunctional c-kit
Nawazish Naqvi, Ming Li, Eiji Yahiro, et al.
Current Pharmaceutical Design
|
November 27, 2012
Chymase inhibitors
Eiji Yahiro, Shin-ichiro Miura, Satoshi Imaizumi, et al.
Current Pharmaceutical Design
|
November 27, 2012
Class- and molecule-specific differential effects of angiotensin II type 1 receptor blockers
Satoshi Imaizumi, Shin-ichiro Miura, Eiji Yahiro, et al.
International Journal of Cardiology. Heart & Vessels
|
February 17, 2018
Improved survival rate after myocardial infarction using an inducible cholesterol efflux (iCE) peptide: FAMP
Eiji Yahiro, Yoshinari Uehara, Emi Kawachi, et al.
Experimental and Clinical Cardiology
|
July 25, 2008
Orally administered levofloxacin as prophylaxis against pacemaker infection
Natsumi Morito, Yoshio Yamanouchi, Sunao Kodama, et al.
Cardiology
|
April 25, 2003
Reperfusion-induced arrhythmias are suppressed by inhibition of the angiotensin II type 1 receptor
Eiji Yahiro, Munehito Ideishi, Li Xing Wang, et al.
Journal of Cardiovascular Pharmacology
|
April 12, 2003
Chymase inhibitor improves survival in hamsters with myocardial infarction
Fumihiro Hoshino, Hidenori Urata, Yukiko Inoue, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 4, 2015
Depressor effect of chymase inhibitor in mice with high salt-induced moderate hypertension
Sankar Devarajan, Eiji Yahiro, Yoshinari Uehara, et al.
Page
of 4